v3.25.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional Paid In Capital
Distributions in Excess of Cumulative Earnings
Accumulated Other Comprehensive (Loss) Income
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     164,635,150        
Beginning balance at Dec. 31, 2023 $ 2,987,002 $ 2,978,579 $ 1,646 $ 3,078,459 $ (105,545) $ 4,019 $ 8,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     10,508,096        
Common stock issuance 244,735 244,735 $ 105 244,630      
Common stock withheld related to net share settlement of equity awards (3,277) (3,277)     (3,277)    
Costs related to issuance of common stock (366) (366)   (366)      
Other comprehensive income (loss) 19,631 19,575       19,575 56
Equity based compensation expense (in shares)     163,140        
Equity-based compensation expense 2,947 2,947 $ 2 2,945      
Dividends declared on common stock and OP Units (50,236) (50,079)     (50,079)   (157)
Net income 47,123 46,975     46,975   148
Ending balance (in shares) at Mar. 31, 2024     175,306,386        
Ending balance at Mar. 31, 2024 3,247,559 3,239,089 $ 1,753 3,325,668 (111,926) 23,594 8,470
Beginning balance (in shares) at Dec. 31, 2023     164,635,150        
Beginning balance at Dec. 31, 2023 2,987,002 2,978,579 $ 1,646 3,078,459 (105,545) 4,019 8,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) 21,379            
Net income 98,798            
Ending balance (in shares) at Jun. 30, 2024     175,330,314        
Ending balance at Jun. 30, 2024 3,252,271 3,243,798 $ 1,753 3,328,082 (111,373) 25,336 8,473
Beginning balance (in shares) at Mar. 31, 2024     175,306,386        
Beginning balance at Mar. 31, 2024 3,247,559 3,239,089 $ 1,753 3,325,668 (111,926) 23,594 8,470
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     23,928        
Costs related to issuance of common stock (228) (228)   (228)      
Other comprehensive income (loss) 1,746 1,742       1,742 4
Equity-based compensation expense 2,642 2,642   2,642      
Dividends declared on common stock and OP Units (51,124) (50,964)     (50,964)   (160)
Net income 51,676 51,517     51,517   159
Ending balance (in shares) at Jun. 30, 2024     175,330,314        
Ending balance at Jun. 30, 2024 $ 3,252,271 3,243,798 $ 1,753 3,328,082 (111,373) 25,336 8,473
Beginning balance (in shares) at Dec. 31, 2024 187,537,592   187,537,592        
Beginning balance at Dec. 31, 2024 $ 3,572,127 3,563,678 $ 1,875 3,658,219 (113,302) 16,886 8,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     9,732,006        
Common stock issuance 278,623 278,623 $ 97 278,526      
Common stock withheld related to net share settlement of equity awards (6,300) (6,300)     (6,300)    
Costs related to issuance of common stock (443) (443)   (443)      
Other comprehensive income (loss) (22,364) (22,295)       (22,295) (69)
Equity based compensation expense (in shares)     242,718        
Equity-based compensation expense 3,968 3,968 $ 2 3,966      
Dividends declared on common stock and OP Units (58,655) (58,368)     (58,368)   (287)
Net income 56,281 56,108     56,108   173
Ending balance (in shares) at Mar. 31, 2025     197,512,316        
Ending balance at Mar. 31, 2025 $ 3,823,237 3,814,971 $ 1,974 3,940,268 (121,862) (5,409) 8,266
Beginning balance (in shares) at Dec. 31, 2024 187,537,592   187,537,592        
Beginning balance at Dec. 31, 2024 $ 3,572,127 3,563,678 $ 1,875 3,658,219 (113,302) 16,886 8,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) (34,780)            
Net income $ 119,651            
Ending balance (in shares) at Jun. 30, 2025 198,138,567   198,138,567        
Ending balance at Jun. 30, 2025 $ 3,837,986 3,829,888 $ 1,981 3,963,899 (118,201) (17,791) 8,098
Beginning balance (in shares) at Mar. 31, 2025     197,512,316        
Beginning balance at Mar. 31, 2025 3,823,237 3,814,971 $ 1,974 3,940,268 (121,862) (5,409) 8,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issuance (in shares)     604,104        
Common stock issuance 20,186 20,186 $ 6 20,180      
Common stock withheld related to net share settlement of equity awards (7) (7)     (7)    
Costs related to issuance of common stock (45) (45)   (45)      
Other comprehensive income (loss) (12,416) (12,382)       (12,382) (34)
Equity based compensation expense (in shares)     22,147        
Equity-based compensation expense 3,497 3,497 $ 1 3,496      
Dividends declared on common stock and OP Units (59,836) (59,544)     (59,544)   (292)
Net income $ 63,370 63,212     63,212   158
Ending balance (in shares) at Jun. 30, 2025 198,138,567   198,138,567        
Ending balance at Jun. 30, 2025 $ 3,837,986 $ 3,829,888 $ 1,981 $ 3,963,899 $ (118,201) $ (17,791) $ 8,098